Skip to main content

letter

. 1992 Aug;45(8):742. doi: 10.1136/jcp.45.8.742-a

PIVKA-II concentrations in patients with cystic fibrosis.

E A Cornelissen, A F van Lieburg, C G van Oostrom, L Monnens

PMCID: PMC495164 PMID: 1401195

742

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bechtold H., Andrassy K., Jähnchen E., Koderisch J., Koderisch H., Weilemann L. S., Sonntag H. G., Ritz E. Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost. 1984 Jul 29;51(3):358–361. [PubMed] [Google Scholar]
Komp D. M., Selden R. F., Jr Coagulation abnormalities in cystic fibrosis. Chest. 1970 Nov;58(5):501–503. doi: 10.1378/chest.58.5.501. [DOI] [PubMed] [Google Scholar]
Lefrere J. J., Armengaud D., Leclerq M., Guillaumont M., Gozin D., Alagille D. Des-gamma-carboxyprothrombin and hepatoblastoma. J Clin Pathol. 1988 Mar;41(3):356–356. doi: 10.1136/jcp.41.3.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
Lefrère J. J., Van Dreden P., Samama M. Elevation of different des-gamma-carboxyproteins in hepatocellular carcinoma. Thromb Haemost. 1987 Dec 18;58(4):1092–1092. [PubMed] [Google Scholar]
Liebman H. A., Furie B. C., Tong M. J., Blanchard R. A., Lo K. J., Lee S. D., Coleman M. S., Furie B. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med. 1984 May 31;310(22):1427–1431. doi: 10.1056/NEJM198405313102204. [DOI] [PubMed] [Google Scholar]
Nelsestuen G. L., Zytkovicz T. H., Howard J. B. The mode of action of vitamin K. Identification of gamma-carboxyglutamic acid as a component of prothrombin. J Biol Chem. 1974 Oct 10;249(19):6347–6350. [PubMed] [Google Scholar]
Soulier J. P., Gozin D., Lefrere J. J. A new method to assay des-gamma-carboxyprothrombin. Results obtained in 75 cases of hepatocellular carcinoma. Gastroenterology. 1986 Nov;91(5):1258–1262. doi: 10.1016/s0016-5085(86)80025-7. [DOI] [PubMed] [Google Scholar]
Widdershoven J., van Munster P., De Abreu R., Bosman H., van Lith T., van der Putten-van Meyel M., Motohara K., Matsuda I. Four methods compared for measuring des-carboxy-prothrombin (PIVKA-II). Clin Chem. 1987 Nov;33(11):2074–2078. [PubMed] [Google Scholar]
de Montalembert M., Lenoir G., Saint-Raymond A., Rey J., Lefrère J. J. Increased PIVKA-II concentrations in patients with cystic fibrosis. J Clin Pathol. 1992 Feb;45(2):180–181. doi: 10.1136/jcp.45.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES